OSCR

Human TDP-43 expression worsens FTD-related phenotypes in progranulin-insufficient mice.

Overview

Authors: Anna K Cook1,2, Benjamin Lin3, Yumo Song1,4, Kelsey M Greathouse1,2, Azariah K Kaplelach1,2, Mackenzie L Love1,2, Skylar E Davis1,2, Anna C Stoll1,2, Justin A Hall1,2, Ahmad R Hakim1,2, Jakub F Hel1,2, Giacynta A Vollmer1,2, Alexandria C Howard1,2, Noelle H Cooper1,2, Phaedra N Manuel1,2, Juliana M Eberhardt1,2, C Ryan Miller3, Ashley S Harms1,2, Jeremy H Herskowitz1,2, Lindsay F Rizzardi1,4, Andrew E Arrant1,2
  1. Killion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
  2. Department of Neurology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
  3. Department of Pathology, Division of Neuropathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
  4. Department of Biochemistry and Molecular Genetics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
Institutions: University of Alabama at Birmingham (United States); UAB Medicine
Journal: Neurobiology of disease, volume 227, article 107475
Dates: published online 8 June 2026; in print September 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1016/j.nbd.2026.107475 · PMID 42264399 · PMCID PMC13427247 · OpenAlex W7163892795
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: human (organism), mouse (organism), Alzheimer's / dementia (population), cellular / molecular (subfield)
Methods: Statistics, Connectivity
Keywords: TDP-43, Progranulin, Frontotemporal dementia
MeSH: DNA-Binding Proteins*, Frontotemporal Dementia*, Progranulins*, Animals, Disease Models, Animal, Humans, Mice, Mice, Transgenic, Phenotype (* major topic)
Topic: Amyotrophic Lateral Sclerosis Research (Neurology, Medicine), according to OpenAlex
Funding: NIA NIH HHS (F30 AG085889, P30 AG086401, R01 AG061800, R01 AG054719); NINDS NIH HHS (T32 NS095775, R01 NS134798, R01 NS128031); National Institute on Aging (R01AG054719, P30AG086401, R01AG061800, F30AG085889); National Institute of Neurological Disorders and Stroke (R01NS134798, T32NS095775, R01NS128031); National Institutes of Health National Cancer Institute (P30CA013148, R01CA258248); NCI NIH HHS (R01 CA258248, P30 CA013148); NIGMS NIH HHS (T32 GM008361); National Institute of General Medical Sciences (T32GM008361)
Citations: not cited yet (Europe PMC); 143 references in the paper
Research resources: GFAP RRID:AB_10013382, pTDP-43 RRID:AB_11182943, NeuN RRID:AB_11205760, c-Fos RRID:AB_2247211, RRID:AB_2935765, CD68 RRID:AB_322219, clone M5/114.15.2 RRID:AB_467562, CD3 RRID:AB_468852, α-tubulin RRID:AB_477579, Ubiquitin RRID:AB_477667, Olig2 RRID:AB_570666, TDP-43 RRID:AB_615042, RRID:IMSR_JAX:012836, Grn+/− mice RRID:MMRRC_036771-JAX

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

Read it in the paper: doi.org/10.1016/j.nbd.2026.107475.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Publisher: — → Elsevier BV

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 21 authors, 3 keywords, 9 MeSH terms, 8 funders, 138 references, 14 RRIDs.

Cite

This paper

Cook, A. K., Lin, B., Song, Y., Greathouse, K. M., Kaplelach, A. K., Love, M. L., Davis, S. E., Stoll, A. C., Hall, J. A., Hakim, A. R., Hel, J. F., Vollmer, G. A., Howard, A. C., Cooper, N. H., Manuel, P. N., Eberhardt, J. M., Miller, C. R., Harms, A. S., Herskowitz, J. H., . . . Arrant, A. E. (2026). Human TDP-43 expression worsens FTD-related phenotypes in progranulin-insufficient mice. Neurobiology of disease, 227, 107475. https://doi.org/10.1016/j.nbd.2026.107475

BibTeX

@article{cook2026human,
author = {Cook, Anna K and Lin, Benjamin and Song, Yumo and Greathouse, Kelsey M and Kaplelach, Azariah K and Love, Mackenzie L and Davis, Skylar E and Stoll, Anna C and Hall, Justin A and Hakim, Ahmad R and Hel, Jakub F and Vollmer, Giacynta A and Howard, Alexandria C and Cooper, Noelle H and Manuel, Phaedra N and Eberhardt, Juliana M and Miller, C Ryan and Harms, Ashley S and Herskowitz, Jeremy H and Rizzardi, Lindsay F and Arrant, Andrew E},
title = {{Human TDP-43 expression worsens FTD-related phenotypes in progranulin-insufficient mice}},
journal = {Neurobiology of disease},
year = {2026},
month = jun,
volume = {227},
pages = {107475},
publisher = {Elsevier BV},
issn = {0969-9961},
doi = {10.1016/j.nbd.2026.107475},
url = {https://doi.org/10.1016/j.nbd.2026.107475},
pmid = {42264399},
pmcid = {PMC13427247}
}

RIS

TY - JOUR
AU - Cook, Anna K
AU - Lin, Benjamin
AU - Song, Yumo
AU - Greathouse, Kelsey M
AU - Kaplelach, Azariah K
AU - Love, Mackenzie L
AU - Davis, Skylar E
AU - Stoll, Anna C
AU - Hall, Justin A
AU - Hakim, Ahmad R
AU - Hel, Jakub F
AU - Vollmer, Giacynta A
AU - Howard, Alexandria C
AU - Cooper, Noelle H
AU - Manuel, Phaedra N
AU - Eberhardt, Juliana M
AU - Miller, C Ryan
AU - Harms, Ashley S
AU - Herskowitz, Jeremy H
AU - Rizzardi, Lindsay F
AU - Arrant, Andrew E
TI - Human TDP-43 expression worsens FTD-related phenotypes in progranulin-insufficient mice
T2 - Neurobiology of disease
J2 - Neurobiol Dis
PY - 2026
DA - 2026/06/08
VL - 227
SP - 107475
SN - 0969-9961
PB - Elsevier BV
DO - 10.1016/j.nbd.2026.107475
UR - https://doi.org/10.1016/j.nbd.2026.107475
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.nbd.2026.107475",
"type": "article-journal",
"title": "Human TDP-43 expression worsens FTD-related phenotypes in progranulin-insufficient mice",
"container-title": "Neurobiology of disease",
"author": [
{
"family": "Cook",
"given": "Anna K"
},
{
"family": "Lin",
"given": "Benjamin"
},
{
"family": "Song",
"given": "Yumo"
},
{
"family": "Greathouse",
"given": "Kelsey M"
},
{
"family": "Kaplelach",
"given": "Azariah K"
},
{
"family": "Love",
"given": "Mackenzie L"
},
{
"family": "Davis",
"given": "Skylar E"
},
{
"family": "Stoll",
"given": "Anna C"
},
{
"family": "Hall",
"given": "Justin A"
},
{
"family": "Hakim",
"given": "Ahmad R"
},
{
"family": "Hel",
"given": "Jakub F"
},
{
"family": "Vollmer",
"given": "Giacynta A"
},
{
"family": "Howard",
"given": "Alexandria C"
},
{
"family": "Cooper",
"given": "Noelle H"
},
{
"family": "Manuel",
"given": "Phaedra N"
},
{
"family": "Eberhardt",
"given": "Juliana M"
},
{
"family": "Miller",
"given": "C Ryan"
},
{
"family": "Harms",
"given": "Ashley S"
},
{
"family": "Herskowitz",
"given": "Jeremy H"
},
{
"family": "Rizzardi",
"given": "Lindsay F"
},
{
"family": "Arrant",
"given": "Andrew E"
}
],
"container-title-short": "Neurobiol Dis",
"volume": "227",
"page": "107475",
"DOI": "10.1016/j.nbd.2026.107475",
"PMID": "42264399",
"PMCID": "PMC13427247",
"ISSN": "0969-9961",
"publisher": "Elsevier BV",
"URL": "https://doi.org/10.1016/j.nbd.2026.107475",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
8
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s13024-026-00944-2
TDP-43: [GU]-ardian of the transcriptome.
Journal: Molecular neurodegeneration
In common: cellular / molecular, 13 references
[2] doi:10.1016/j.isci.2026.115720
Progranulin deficiency in the brain activates an insulin signaling pathway that may promote neurodegeneration.
Journal: iScience
In common: cellular / molecular, 11 references
[3] doi:10.1126/sciadv.ady0256
Isoform-specific steric zippers drive aberrant assembly and mislocalization of shortened TDP-43.
Journal: Science advances
In common: cellular / molecular, 8 references
[4] doi:10.1172/jci190035 [code]
TGF-β signaling promotes astroglial activation and TDP-43 proteinopathy in organoid models of frontotemporal lobar degeneration.
Journal: The Journal of clinical investigation
In common: Alzheimer's / dementia, mouse, cellular / molecular, 6 references
[5] doi:10.1038/s43587-026-01166-3
Therapeutic targeting of the conserved region within the low-complexity domain of TDP-43 is neuroprotective and extends survival in amyotrophic lateral sclerosis mice.
Journal: Nature aging
In common: mouse, 5 references
[6] doi:10.1016/j.cell.2026.05.047 [code]
An emergent disease-associated motor neuron state precedes cell death in ALS.
Journal: Cell
In common: mouse, cellular / molecular, 6 references
[7] doi:10.7554/elife.105528 [code]
Functional specialization of mPFC-BLA and mPFC-NAc pathways in affective state representation.
Journal: eLife
In common: mouse, 4 references
[8] doi:10.1038/s41588-026-02570-6 [code]
Somatic mosaicism in ALS and FTD identifies focal mutations associated with widespread degeneration.
Journal: Nature genetics
In common: Alzheimer's / dementia, cellular / molecular, 4 references
[9] doi:10.1016/j.isci.2026.116054 [code]
Global transcriptional changes across multiple isogenic <i>C9orf72</i> patient iPSC-derived neurons.
Journal: iScience
In common: cellular / molecular, 5 references
[10] doi:10.1002/glia.70163
A Cross-Disease Microglial Transcriptional Program Characterizes Neurodegeneration and Highlights SPP1 as a Biomarker.
Journal: Glia
In common: Alzheimer's / dementia, mouse, cellular / molecular, 4 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.